MAHAJNEH, ALLIA
 Distribuzione geografica
Continente #
EU - Europa 129
NA - Nord America 91
AS - Asia 68
OC - Oceania 3
Totale 291
Nazione #
US - Stati Uniti d'America 90
IE - Irlanda 42
SG - Singapore 35
IT - Italia 34
RU - Federazione Russa 20
HK - Hong Kong 16
CN - Cina 15
DE - Germania 15
SE - Svezia 8
NL - Olanda 4
AU - Australia 3
FI - Finlandia 2
AT - Austria 1
CA - Canada 1
CH - Svizzera 1
GB - Regno Unito 1
IN - India 1
LA - Repubblica Popolare Democratica del Laos 1
UA - Ucraina 1
Totale 291
Città #
Dublin 42
Singapore 32
Hong Kong 16
New York 16
Santa Clara 16
Chandler 14
Frankfurt am Main 14
Milan 13
Shanghai 10
Ashburn 4
Florence 4
Hangzhou 4
Amsterdam 3
Darlington 3
Carate Brianza 2
Airuno 1
Brescia 1
Dallas 1
Deiva Marina 1
Helsinki 1
Huizen 1
Lappeenranta 1
London 1
Los Angeles 1
Melzo 1
Ottawa 1
Pune 1
Rho 1
Romola 1
Vienna 1
Vientiane 1
Zurich 1
Totale 210
Nome #
Plasma proteome investigation of COVID-19 patients with different outcomes through an untargeted label-free LC-MS/MS approach. 81
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients. 76
Proteomic monitoring by label-free nLC-MS/MS of human platelet lysates for a standardized and optimized production 32
Plasma proteomic signatures related to COVID-19 disease severity by an untargeted nLC-ESI-MS/MS approach 31
Characterization of SARS-CoV-2 proteins and human proteome in COVID-19 patients’ saliva and plasma: an untargeted mass spectrometry approach 31
Proteomic and glycoproteomic approaches based on nLC-ESI MS/MS for exploring cancer matrisome: explorative study 30
Proteomic characterization and comparison of human platelet lysates for a standardized and high quality production 28
Totale 309
Categoria #
all - tutte 1.904
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.904


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202367 0 13 6 13 5 12 3 7 5 0 2 1
2023/2024132 1 0 5 27 12 39 25 3 9 2 2 7
2024/2025110 9 40 26 15 20 0 0 0 0 0 0 0
Totale 309